Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy

Diabetic Medicine

Volumn 29, Issue 6, 2012, Pages 771-775

  Korzon Burakowska, A ^a   Jakobkiewicz Banecka J ^b   Fiedosiuk, A ^b   Petrova, N ^c   Koblik, T ^d   Gabig Ciminska M ^b   Edmonds, M ^c   Malecki M T ^d   Wegrzyn, G ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF GDA SK   (Poland)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Charcot neuroarthropathy; Diabetic foot; Diabetic neuropathy; Osteoprotegerin gene; Polymorphism

Indexed keywords

C REACTIVE PROTEIN; DNA; OSTEOPROTEGERIN;

ADULT; AGE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETIC CHARCOT NEUROARTHROPATHY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DNA ISOLATION; DNA POLYMORPHISM; EQUILIBRIUM CONSTANT; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC JOINT DISEASE; POLAND;

ADULT; ARTHROPATHY, NEUROGENIC; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84861163558     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03442.x     Document Type: Article

References (15)

1. Young M, Marshall A, Adams J, Selby PL, Boulton AJ. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 1995; 18: 34-38.
2. Rajbhandari S, Jenkins R, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002; 45: 1085-1096.
3. Frykberg R, Belczyk R. Epidemiology of the Charcot foot. Clin Podiatr Med Surg 2008; 25: 17-28.
4. Jeffcoate W. Vascular calcification and osteolysis in diabetic neuropathy - is RANK-L the missing link? Diabetologia 2004; 47: 1488-1492.
5. Jones D, Kong Y, Penninger J. Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis 2002; 61(Suppl 2): ii32-39.
6. Terpos E, Szydlo R, Apperley J, Hatjiharissi E, Politou M, Meletis J et al. Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. Blood 2003; 102: 1064-1069.
7. Mabilleau G, Petrova N, Edmonds M, Sabokbar A. Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia 2008; 51: 1035-1040.
8. Langdahl B, Carstens M, Stenkjaer L, Eriksen EF. Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J Bone Miner Res 2002; 17: 1245-1255.
9. Pitocco D, Zelano G, Gioffrè G, Di Stasio E, Zaccardi F, Martini F et al. Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic charcot neuroarthropathy: a case-control study. Diabetes Care 2009; 32: 1694-1697.
10. Sanders LJ, Frykberg RG. Charcot neuroarthropathy of the foot. In: Bowker JH, Pfeifer MA, eds. Levin and O'Neals The Diabetic Foot, 6th edn. Saint Louis: Mosby, 2001; 439-466.
11. Cavanagh P, Young M, Adams J, Vickers KL, Boulton AJM. Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care 1994; 17: 201-209.
12. Young M, Breddy J, Veves A, Boulton A. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994; 17: 557-560.
13. Morinaga T, Nakagawa N, Yasuda H, Tsuda E, Higashio K. Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor. Eur J Biochem 1998; 254: 685-691.
14. Arko B, Prezelj J, Komel R, Kocijancic A, Hudler P, Marc J. Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. J Clin Endocrinol Metab 2002; 87: 4080-4084.
15. Brändström H, Gerdhem P, Stiger F, Obrant KJ, Melhus H, Ljunggren O et al. Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women. Calcif Tissue Int 2004; 74: 18-24.